Skip to content
10-Q

Quarterly Report

VAPORIN, INC.

0001493152-14-001497

← back to feed
Filed
May 15, 2014 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2014 · May 1, 2014 167.51M sh
Operating Cash Flow Q1 2014 · Mar 31, 2014 −$893.36K
Operating Cash Flow restated Q1 2014 · Mar 31, 2013 $5.59K
Cash And Equivalents Q1 2014 · Mar 31, 2014 $225.36K
Cash And Equivalents Q1 2014 · Dec 31, 2013 $25.22K
Cash And Equivalents restated Q1 2014 · Mar 31, 2013 $3.3K
Stockholders Equity Q1 2014 · Mar 31, 2014 $333.56K
Stockholders Equity Q1 2014 · Dec 31, 2013 $43.18K
Total Liabilities Q1 2014 · Mar 31, 2014 $672.96K
Total Liabilities Q1 2014 · Dec 31, 2013 $368.02K
Current Assets Q1 2014 · Mar 31, 2014 $988.99K
Current Assets Q1 2014 · Dec 31, 2013 $390.53K
Total Assets Q1 2014 · Mar 31, 2014 $1.01M
Total Assets Q1 2014 · Dec 31, 2013 $411.2K
Sga Expense Q1 2014 · Mar 31, 2014 $575.31K
Sga Expense restated Q1 2014 · Mar 31, 2013 $46.13K
Net Income Q1 2014 · Mar 31, 2014 −$1.14M
Net Income restated Q1 2014 · Mar 31, 2013 −$46.14K
Operating Income Q1 2014 · Mar 31, 2014 −$756.89K
Operating Income restated Q1 2014 · Mar 31, 2013 −$46.13K
Gross Profit Q1 2014 · Mar 31, 2014 $67.33K
Cost Of Revenue Q1 2014 · Mar 31, 2014 $115.46K
Revenue Q1 2014 · Mar 31, 2014 $182.79K
Capex restated Q1 2014 · Mar 31, 2013 $2.29K